United States · FDA National Drug Code directory
Allopurinol
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0603-2116_14909994-d957-4d81-a6e6-68d64107fd1b
- Product NDC
- 0603-2116
- Form
- TABLET
- Composition / generic term
- allopurinol
- Labeler
- Par Health USA, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20030627
- Source listing expiry
- 20271231
Source-listed ingredients
- ALLOPURINOL — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE, PLASTIC (0603-2116-21) · 0603-2116-21
- 500 TABLET in 1 BOTTLE, PLASTIC (0603-2116-28) · 0603-2116-28
- 1000 TABLET in 1 BOTTLE, PLASTIC (0603-2116-32) · 0603-2116-32
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →